摘要
目的:冠状动脉粥样硬化性心脏病(简称,冠心病)伴糖尿病患者基于IVUS(血管内超声)指导开展冠状动脉介入疗法的有效性分析。方法:选择2019年7月~2020年4月于本院接受冠状动脉介入治疗的74例冠心病伴糖尿病患者为研究对象,参考患者入院时间以及37例单组区间条件划分为对照组(常规实施冠状动脉介入治疗)、IVUS组(基于IVUS指导开展冠状动脉介入治疗);比对两组造影剂使用量、支架置入数、支架直径、支架长度、手术成本。结果:IVUS组相对比对照组而言,造影剂使用量以及支架置入数较少,支架直径较大,长度较短,手术成本较低,差异统计学意义明显(P<0.05)。结论:基于IVUS指导对冠心病伴糖尿病患者行冠状动脉介入治疗,可减少造影剂使用量与支架置入量,且手术成本较低,有利于患者接受。
Objective:Patients with diabetes with coronary heart disease(CHD)based on IVUS,intravascular ultrasound guiding the effectiveness analysis of coronary artery intervention therapy.Methods:74 patients with coronary heart disease and diabetes who received coronary interventional therapy in our hospital from July 2019 to April 2020 were selected as the research objects.The patients were divided into the control group with reference to the time of admission and 37 single-group interval conditions(routine implementation).Coronary interventional therapy,IVUS group(based on IVUS guidance to carry out coronary interventional therapy);compare the two groups of contrast medium usage,number of stents,stent diameter,stent length,and surgical cost.Results:IVUS group compared with than the control group,the contrast agent usage and less number of stent placement,bracket larger diameter and shorter length,low operation cost,statistically significant difference(P<0.05).Conclusion:IVUS guidance based on coronary heart disease patients with diabetes with coronary artery intervention treatment,can reduce the contrast agent usage and amount of stent placement,and lower operation cost,is beneficial to patients.
作者
杨丹
YANG Dan(ZHU Xian-yi Memorial Hospital of Tianjin Medical University,Tianjin Institute of Endocrinology,Key Laboratory of Hormone and Development of National Health Commission,Tianjin Key Laboratory of Metabolic Diseases,Tianjin 300400)
出处
《中国医疗器械信息》
2021年第7期102-103,共2页
China Medical Device Information
